LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Lallemand joins EuropaBio: new global opportunities for industrial biotechnology

18/05/2021
PRESS RELEASE

Lallemand joins EuropaBio: new global opportunities for industrial biotechnology

Brussels, 19 May 2021 – EuropaBio is pleased to announce that Lallemand has joined as a corporate member.

Founded in Canada over a century ago, today the company employs over 4500 people with a world-wide presence.

Lallemand has a proprietary collection of thousands of individually identified strains of yeast and bacteria. With the goal of reproducing, managing, and optimizing natural fermentation processes, Lallemand offers its customers not only the precise microorganism(s) and or derivative(s) that fit their specific needs, but also the support, knowledge, and expertise that comes with over a hundred years of continuous improvements, research, development and innovation in microbial industrialisation.

As part of EuropaBio, it will contribute to enabling best practices and access to wholesome, safe, sustainable, nutritious, and healthy food and or products, ensuring that animals and humans lead healthy lives and make our world a generally better one.

EuropaBio Director-General Dr. Claire Skentelbery says “Lallemand is a fantastic addition to the EuropaBio community, bringing next generation industrial biotechnology to life for the revolution in sustainability that we need to deliver the Green Deal. Their expertise and multi-sector experience sits at the core of EuropaBio activities and mission.

Lallemand’s Executive Vice President and COO, Bill Nankervis, added “At Lallemand we are passionate about biotechnology and the potential to create value and improve the environment and the quality of life of people (and animals) across the World. We are committed to our customers and partners in Europe and it makes sense to contribute to assuring the advancement of industrial biotechnology through membership of EuropaBio”.

Lallemand joins EuropaBio


Download
2021_05_G_PR_Lallemand-joins-EuropaBioDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

18/09/2023

Genopole joins EuropaBio: French biotechnology on a global scale


Read more
14/09/2023

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products


Read more
14/09/2023

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework


Read more

Important links

  • Genopole joins EuropaBio: French biotechnology on a global scale
  • Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member